Fort Worth, Texas-based biotech company Nuvothera is growing its consumer healthcare offerings. The company, which earlier this year launched OTC psoriasis treatment Prosoria, has launched its Super-Micronized Turmeric Curcumin supplement.
The product looks to address an issue that Nuvothera CEO Arthur Clapp said plagues most turmeric supplements — a lack of bioavailability of curcumin, which is hydrophobic and resistant to absorption into the bloodstream when taken orally. Rather than use a secondary agent to boost absorption, Nuvothera uses micronization to reduce the size of the turmeric particles alongside microencapsulation to help turmeric particles survive the digestive tract and make it into the bloodstream, the company said.
“Open up a typical curcumin capsule and pour it in a glass of water,” Clapp said. “You’ll see the contents float on top of the water. When you pour our Super-Micronized Turmeric Curcumin on water, it dissolves instantly. That’s the difference particle size makes. Our turmeric curcumin supplement absorbs easily and is selectively taken up by our bodies without the need for black pepper or additional absorption enhancers.”
Clapp said the Super Micronized Turmeric Curcumin supplement has shown 126 times greater potency than other brands.
The product currently is available on Nuvothera’s website and Amazon.com, and retails for between $30 and $40 per bottle.